These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11298336)

  • 1. Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load.
    Oxenius A; Günthard HF; Hirschel B; Fidler S; Weber JN; Easterbrook PJ; Bell JI; Phillips RE; Price DA
    Eur J Immunol; 2001 Apr; 31(4):1115-21. PubMed ID: 11298336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.
    Oxenius A; Sewell AK; Dawson SJ; Günthard HF; Fischer M; Gillespie GM; Rowland-Jones SL; Fagard C; Hirschel B; Phillips RE; Price DA;
    J Clin Immunol; 2002 Nov; 22(6):363-74. PubMed ID: 12462336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection.
    Sester M; Sester U; Köhler H; Schneider T; Deml L; Wagner R; Mueller-Lantzsch N; Pees HW; Meyerhans A
    AIDS; 2000 Dec; 14(17):2653-60. PubMed ID: 11125883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
    Seth A; Markee J; Hoering A; Sevin A; Sabath DE; Schmitz JE; Kuroda MJ; Lifton MA; Hirsch MS; Collier AC; Letvin NL; McElrath MJ
    J Infect Dis; 2001 Mar; 183(5):722-9. PubMed ID: 11181148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.
    Scott-Algara D; Buseyne F; Blanche S; Rouzioux C; Jouanne C; Romagné F; Rivière Y
    J Infect Dis; 2001 Jun; 183(11):1565-73. PubMed ID: 11343205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
    Ruiz A; Blanch-Lombarte O; Jimenez-Moyano E; Ouchi D; Mothe B; Peña R; Galvez C; Genescà M; Martinez-Picado J; Goulder P; Barnard R; Howell B; Clotet B; Prado JG
    Front Immunol; 2018; 9():3162. PubMed ID: 30723480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-E-restricted CD8
    La Manna MP; Orlando V; Prezzemolo T; Di Carlo P; Cascio A; Delogu G; Poli G; Sullivan LC; Brooks AG; Dieli F; Caccamo N
    Am J Respir Cell Mol Biol; 2020 Apr; 62(4):430-439. PubMed ID: 31697586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E-restricted, Gag-specific CD8
    Yang H; Rei M; Brackenridge S; Brenna E; Sun H; Abdulhaqq S; Liu MKP; Ma W; Kurupati P; Xu X; Cerundolo V; Jenkins E; Davis SJ; Sacha JB; Früh K; Picker LJ; Borrow P; Gillespie GM; McMichael AJ
    Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33766848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.
    Crawford TQ; Hecht FM; Pilcher CD; Ndhlovu LC; Barbour JD
    PLoS One; 2013; 8(10):e77412. PubMed ID: 24143233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy.
    Rehr M; Cahenzli J; Haas A; Price DA; Gostick E; Huber M; Karrer U; Oxenius A
    J Virol; 2008 Apr; 82(7):3391-404. PubMed ID: 18199637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
    Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
    J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Low Frequency of IL-17-Producing CD8
    Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
    Front Immunol; 2018; 9():2502. PubMed ID: 30420859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapy.
    Huang XL; Fan Z; Borowski L; Mailliard RB; Rolland M; Mullins JI; Day RD; Rinaldo CR
    PLoS One; 2010 Sep; 5(9):e12936. PubMed ID: 20886040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
    Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
    AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.